NCT06462859

Brief Summary

The purpose of this study is to compare the effects of sensory integration therapy (SIT) applied in addition to neurodevelopmental treatment (NDT) on Motor Function, Balance, and Trunk Control in diplegia cerebral palsy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 17, 2024

Completed
Last Updated

June 17, 2024

Status Verified

June 1, 2024

Enrollment Period

4 months

First QC Date

June 11, 2024

Last Update Submit

June 14, 2024

Conditions

Keywords

Cerebral PalsyDiplegia TypeTreatmentBalance

Outcome Measures

Primary Outcomes (1)

  • Gross Motor Function Measure-88 (GMFM-88)

    The evaluation is organized into sections based on different motor skills: Section A covers lying and rolling, Section B includes sitting, Section C focuses on crawling and kneeling, Section D assesses standing, and Section E includes walking, running, and jumping. Altogether, there are 88 items: Section A (17 items), Section B (20 items), Section C (14 items), Section D (13 items), and Section E (24 items). The minimum clinically important difference (MCID) ranges from 0.8 to 1.6 for a medium effect size and 1.3 to 2.6 for a larger effect size.

    8 weeks

Secondary Outcomes (2)

  • Pediatric Balance Scale (PBS)

    8 weeks

  • Trunk Control Measurement Scale (TCMS)

    8 weeks

Study Arms (2)

The experimental group

EXPERIMENTAL

The experimental group received sensory integration therapy in addition to the NDT program.Both groups participated in NDT sessions for 45 minutes, three times a week, over a span of 8 weeks.

Other: Sensory Integration Therapy GroupOther: Neurodevelopmental Treatment Group

Control Group

OTHER

The NDT program was customized for each child, incorporating a unique blend of static and dynamic balance exercises, coordination exercises, mobility exercises, and strength training exercises.Both groups participated in NDT sessions for 45 minutes, three times a week, over a span of 8 weeks.

Other: Neurodevelopmental Treatment Group

Interventions

The experimental group received sensory integration therapy in addition to the NDT program. The NDT program is customized for each child, featuring a unique blend of static and dynamic balance exercises, coordination exercises, mobility exercises, and strength training exercises. Participants attended 45-minute NDT and sensory integration sessions three times a week for 8 weeks. Sensory integration therapy, visual perception activities (block design, shape recognition in pictures, puzzles, matching geometric shapes and letters, numbers and classification exercises), body awareness activities (showing body parts, drawing life-size drawings, turning left and right, recognizing body parts by touching ), tactile perception exercises (feeling and touching various textures and shapes) and visual-motor coordination training (eye tracking exercises, activities with moving objects and panel activities).

The experimental group

The NDT program is customized for each child, featuring a mix of static and dynamic balance exercises, coordination exercises, mobility exercises, and strength training exercises. He attended 45-minute NDT sessions three times a week for 8 weeks. There is no treatment or medication other than NDT.

Control GroupThe experimental group

Eligibility Criteria

Age4 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Participants must be between the ages of 4 and 17.
  • Participants must be classified as Level II, III, or IV according to the Gross Motor Function Classification System (GMFCS).

You may not qualify if:

  • Participants who had previously received sensory integration therapy, - Undergone Botulinum Toxin-A injections, or surgical interventions in the past year.
  • Participants who were using pharmacological agents affecting muscle tone.
  • Participants with an uncontrolled history of epilepsy.
  • Participants who were unable to attend the study regularly.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ziya Special Education and Rehabilitation Center

Istanbul, Kagıthane, 34408, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Ayşen Canan Pakeloğlu, MSc

    Halic University

    PRINCIPAL INVESTIGATOR
  • Seda Saka, Asst. Prof.

    Halic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Information regarding the allocation of each group was not provided and outcome assessment was performed by an investigator blinded to group allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two groups with a neurodevelopmental treatment control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc Student

Study Record Dates

First Submitted

June 11, 2024

First Posted

June 17, 2024

Study Start

January 1, 2020

Primary Completion

April 30, 2020

Study Completion

April 30, 2020

Last Updated

June 17, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations